118 related articles for article (PubMed ID: 27554866)
21. Study on chemical analysis, antioxidant and in vitro antifungal activities of essential oil from wild Vitex agnus-castus L. seeds growing in area of Argan Tree of Morocco against clinical strains of Candida responsible for nosocomial infections.
Asdadi A; Hamdouch A; Oukacha A; Moutaj R; Gharby S; Harhar H; El Hadek M; Chebli B; Idrissi Hassani LM
J Mycol Med; 2015 Dec; 25(4):e118-27. PubMed ID: 26611404
[TBL] [Abstract][Full Text] [Related]
22. Antifungal effect and action mechanism of antimicrobial peptide polybia-CP.
Wang K; Jia F; Dang W; Zhao Y; Zhu R; Sun M; Qiu S; An X; Ma Z; Zhu Y; Yan J; Kong Z; Yan W; Wang R
J Pept Sci; 2016 Jan; 22(1):28-35. PubMed ID: 26680221
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of antifungal activity of standardized extract of Salvia rhytidea Benth. (Lamiaceae) against various Candida isolates.
Salari S; Bakhshi T; Sharififar F; Naseri A; Ghasemi Nejad Almani P
J Mycol Med; 2016 Dec; 26(4):323-330. PubMed ID: 27499461
[TBL] [Abstract][Full Text] [Related]
24. Antifungal activity and mode of action of thymol and its synergism with nystatin against Candida species involved with infections in the oral cavity: an in vitro study.
de Castro RD; de Souza TM; Bezerra LM; Ferreira GL; Costa EM; Cavalcanti AL
BMC Complement Altern Med; 2015 Nov; 15():417. PubMed ID: 26601661
[TBL] [Abstract][Full Text] [Related]
25. Novel synthetic anti-fungal tripeptide effective against Candida krusei.
Gill K; Kumar S; Xess I; Dey S
Indian J Med Microbiol; 2015; 33(1):110-6. PubMed ID: 25560012
[TBL] [Abstract][Full Text] [Related]
26. In vitro activity of essential oil from Ocimum gratissimum L. against four Candida species.
Nakamura CV; Ishida K; Faccin LC; Filho BP; Cortez DA; Rozental S; de Souza W; Ueda-Nakamura T
Res Microbiol; 2004 Sep; 155(7):579-86. PubMed ID: 15313260
[TBL] [Abstract][Full Text] [Related]
27. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
28. Synergistic antifungal activity of statin-azole associations as witnessed by Saccharomyces cerevisiae- and Candida utilis-bioassays and ergosterol quantification.
Cabral ME; Figueroa LI; Fariña JI
Rev Iberoam Micol; 2013 Jan; 30(1):31-8. PubMed ID: 23069981
[TBL] [Abstract][Full Text] [Related]
29. Antifungals: Mechanism of Action and Drug Resistance.
Prasad R; Shah AH; Rawal MK
Adv Exp Med Biol; 2016; 892():327-349. PubMed ID: 26721281
[TBL] [Abstract][Full Text] [Related]
30. Susceptibility of Candida species isolated from immunocompromised patients to antifungal agents.
Badiee P; Alborzi A; Shakiba E; Farshad S; Japoni A
East Mediterr Health J; 2011 May; 17(5):425-30. PubMed ID: 21796956
[TBL] [Abstract][Full Text] [Related]
31. β-Asarone, an active principle of Acorus calamus rhizome, inhibits morphogenesis, biofilm formation and ergosterol biosynthesis in Candida albicans.
Rajput SB; Karuppayil SM
Phytomedicine; 2013 Jan; 20(2):139-42. PubMed ID: 23123225
[TBL] [Abstract][Full Text] [Related]
32. A diterpenoid taxodone from Metasequoia glyptostroboides with antimycotic potential against clinical isolates of Candida species.
Bajpai VK; Park YH; Kang SC
J Mycol Med; 2015 Mar; 25(1):e31-8. PubMed ID: 25637428
[TBL] [Abstract][Full Text] [Related]
33. Insights into the mode of action of anticandidal herbal monoterpenoid geraniol reveal disruption of multiple MDR mechanisms and virulence attributes in Candida albicans.
Singh S; Fatima Z; Hameed S
Arch Microbiol; 2016 Jul; 198(5):459-72. PubMed ID: 26935560
[TBL] [Abstract][Full Text] [Related]
34. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
Ozcan SK; Mutlu B; Dündar D; Willke A
Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
[TBL] [Abstract][Full Text] [Related]
35. In vivo activity of terpinen-4-ol, the main bioactive component of Melaleuca alternifolia Cheel (tea tree) oil against azole-susceptible and -resistant human pathogenic Candida species.
Mondello F; De Bernardis F; Girolamo A; Cassone A; Salvatore G
BMC Infect Dis; 2006 Nov; 6():158. PubMed ID: 17083732
[TBL] [Abstract][Full Text] [Related]
36. Minimum inhibitory concentrations of amphotericin B, azoles and caspofungin against Candida species are reduced by farnesol.
Cordeiro RA; Teixeira CE; Brilhante RS; Castelo-Branco DS; Paiva MA; Giffoni Leite JJ; Lima DT; Monteiro AJ; Sidrim JJ; Rocha MF
Med Mycol; 2013 Jan; 51(1):53-9. PubMed ID: 22712455
[TBL] [Abstract][Full Text] [Related]
37. Antifungal activity of plant-derived essential oils on Candida tropicalis planktonic and biofilms cells.
Souza CM; Pereira Junior SA; Moraes Tda S; Damasceno JL; Amorim Mendes S; Dias HJ; Stefani R; Tavares DC; Martins CH; Crotti AE; Mendes-Giannini MJ; Pires RH
Med Mycol; 2016 Jul; 54(5):515-23. PubMed ID: 26868902
[TBL] [Abstract][Full Text] [Related]
38. Lichen endophyte derived pyridoxatin inactivates Candida growth by interfering with ergosterol biosynthesis.
Chang W; Zhang M; Li Y; Li X; Gao Y; Xie Z; Lou H
Biochim Biophys Acta; 2015 Sep; 1850(9):1762-71. PubMed ID: 25960388
[TBL] [Abstract][Full Text] [Related]
39. [Susceptibility to miconazole and itraconazole of Candida strains isolated from hospitalized and outpatient clinic patients].
Kurnatowska AK; Kwaśniewska J
Wiad Parazytol; 2009; 55(4):415-23. PubMed ID: 20209818
[TBL] [Abstract][Full Text] [Related]
40. In vitro activity of voriconazole against Candida species isolated in Taiwan.
Yang YL; Cheng HH; Lo HJ
Int J Antimicrob Agents; 2004 Sep; 24(3):294-6. PubMed ID: 15325436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
